Target Name: PALM2
NCBI ID: G114299
Other Name(s): A kinase (PRKA) anchor protein 2 | OTTHUMP00000021890 | OTTHUMP00000215852 | PALM2_HUMAN | Paralemmin-2 (isoform a) | PALM2 variant 1 | Paralemmin-2 (isoform b) | Paralemmin 2, transcript variant b | OTTHUMP00000215851 | OTTHUMP00000021889 | Paralemmin-2 | PALM2 variant b | AKAP2 | OTTHUMP00000021888 | Paralemmin 2, transcript variant 1

PALM2: A Kinase Anchor Protein 2 and Potential Drug Target

PALM2 (Protein-Amino Ligation Module 2) is a 21-kDa protein that is expressed in various cell types, including neurons, glial cells, and blood vessels. PALM2 is a component of the protein-protein interaction (PPI) network and has been implicated in various cellular processes, including cell signaling, migration, and invasion. In recent years, research has focused on the potential of PALM2 as a drug target or biomarker.

During the review, we will discuss the current understanding of PALM2 and its potential as a drug target. We will explore the various functions of PALM2 and its role in cellular processes, as well as its potential as a drug target.

PALM2 Functions and Potential Therapeutic Applications

PALM2 is involved in several cellular processes that are crucial for normal cellular function. One of its key functions is the regulation of cell-cell interactions and the formation of tight junctions, which are essential for maintaining tissue structure and function. PALM2 has been shown to play a critical role in the formation of tight junctions and has been implicated in various types of cancer, including neuro cancer.

In addition to its role in cell-cell interactions, PALM2 is also involved in the regulation of cell signaling pathways. Its anchor protein 2 (AP-2) domain has been shown to play a crucial role in the regulation of T-cell signaling by the kinase PD-L1. PALM2 has also been shown to play a critical role in the regulation of neurotransmitter signaling pathways, including the regulation of serotonin and dopamine release.

PALM2 has also been shown to be involved in the regulation of cellular processes that are crucial for the development and maintenance of tissues. For example, PALM2 has been shown to play a critical role in the regulation of cell proliferation and has been implicated in the development of various types of cancer. In addition, PALM2 has been shown to play a crucial role in the regulation of cell survival and has been implicated in the development of neurodegenerative diseases.

PALM2 as a Drug Target

The potential of PALM2 as a drug target is based on its involvement in various cellular processes that are crucial for normal cellular function. One of its key functions is the regulation of cell-cell interactions and the formation of tight junctions, which are essential for maintaining tissue structure and function. PALM2 has been shown to play a critical role in the formation of tight junctions and has been implicated in various types of cancer, including neuro cancer.

In addition to its role in cell-cell interactions, PALM2 is also involved in the regulation of cell signaling pathways. Its anchor protein 2 (AP-2) domain has been shown to play a crucial role in the regulation of T-cell signaling by the kinase PD-L1. PALM2 has also been shown to play a critical role in the regulation of neurotransmitter signaling pathways, including the regulation of serotonin and dopamine release.

The potential of PALM2 as a drug target is based on its involvement in various cellular processes that are crucial for normal cellular function. One of its key functions is the regulation of cell-cell interactions and the formation of tight junctions, which are essential for maintaining tissue structure and function. PALM2 has been shown to play a critical role in the formation of tight junctions and has been implicated in various types of cancer, including neuro cancer.

Conclusion

PALM2 is a protein that is involved in various cellular processes that are crucial for normal cellular function. Its anchor protein 2 (AP-2) domain has been shown to play a crucial role in the regulation of T-cell signaling by the kinase PD-L1 and has been implicated in various types of cancer, including neuro cancer. In addition, PALM2 has

Protein Name: Paralemmin 2, Transcript Variant 1

More Common Targets

PALM2AKAP2 | PALM3 | PALMD | Palmitoyltransferase | PALS1 | PALS2 | PAM | PAM16 | PAMR1 | PAN2 | PAN3 | PAN3-AS1 | Pancreas transcription factor 1 complex | PANDAR | PANK1 | PANK2 | PANK3 | PANK4 | Pantothenate Kinase | PANTR1 | PANX1 | PANX2 | PANX3 | PAOX | PAPLN | PAPOLA | PAPOLA-DT | PAPOLB | PAPOLG | PAPPA | PAPPA-AS1 | PAPPA-AS2 | PAPPA2 | PAPSS1 | PAPSS2 | PAQR3 | PAQR4 | PAQR5 | PAQR6 | PAQR7 | PAQR8 | PAQR9 | PAR Receptor | PAR-3-PAR-6B-PRKCI complex | Parathyroid Hormone Receptors (PTHR) | PARD3 | PARD3B | PARD6A | PARD6B | PARD6G | PARD6G-AS1 | PARG | PARGP1 | PARK7 | PARL | PARM1 | PARM1-AS1 | PARN | PARP1 | PARP10 | PARP11 | PARP12 | PARP14 | PARP15 | PARP16 | PARP2 | PARP3 | PARP4 | PARP6 | PARP8 | PARP9 | PARPBP | PARS2 | PART1 | PARTICL | PARVA | PARVB | PARVG | Parvovirus initiator complex | PASD1 | PASK | Patatin-like phospholipase domain-containing protein | PATE1 | PATE2 | PATE3 | PATE4 | PATJ | PATL1 | PATL2 | PATZ1 | PAUPAR | PAWR | PAX1 | PAX2 | PAX3 | PAX4 | PAX5 | PAX6 | PAX6-AS1 | PAX7